price
KR
NASDAQ · KROS
Keros Therapeutics, Inc.
Healthcare · Biotechnology
$11.28
Down-$0.09 (-0.80%)
Updated Sep 30, 2026, 1:02 AM
SID Score
6.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 878.88M
- P/E ratio
- 13.67
- Dividend yield
- 0.00%
- 52-week range
- $9.69 – $12.65
- Volume
- 208.64K
- Avg. volume
- 987.56K
Price performance · KROS
KROS price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Sep 28, 2026
KROS closed at $11.28 after 19 trading sessions, up 1.90% for the selected period.
- Last close
- $11.28
- Period change
- +1.90%
- Period low
- $10.74
- Period high
- $11.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | $11.33 | $11.41 | $10.925 | $11.28 | 208.64K |
| Sep 25, 2026 | $11.54 | $11.70 | $11.285 | $11.62 | 216.07K |
| Sep 24, 2026 | $11.60 | $11.60 | $10.97 | $11.55 | 284.44K |
| Sep 23, 2026 | $11.68 | $11.82 | $11.47 | $11.63 | 157.54K |
| Sep 22, 2026 | $11.54 | $12.05 | $11.43 | $11.73 | 189.82K |
| Sep 21, 2026 | $11.31 | $11.60 | $11.08 | $11.48 | 120.72K |
| Sep 18, 2026 | $11.32 | $11.40 | $11.10 | $11.19 | 302.48K |
| Sep 17, 2026 | $10.87 | $11.39 | $10.83 | $11.36 | 274.09K |
| Sep 16, 2026 | $11.23 | $11.23 | $10.70 | $10.74 | 273.99K |
| Sep 15, 2026 | $11.16 | $11.21 | $10.72 | $11.17 | 199.98K |
| Sep 14, 2026 | $11.10 | $11.34 | $10.98 | $11.21 | 342.16K |
| Sep 11, 2026 | $11.25 | $11.34 | $11.025 | $11.08 | 143.83K |
| Sep 10, 2026 | $11.16 | $11.20 | $11.00 | $11.17 | 128.79K |
| Sep 9, 2026 | $11.475 | $11.82 | $11.21 | $11.31 | 188.51K |
| Sep 8, 2026 | $11.16 | $11.31 | $10.98 | $11.17 | 73.05K |
| Sep 4, 2026 | $11.03 | $11.40 | $11.02 | $11.32 | 65.64K |
| Sep 3, 2026 | $11.27 | $11.32 | $10.9173 | $11.11 | 148.71K |
| Sep 2, 2026 | $11.07 | $11.49 | $10.97 | $11.23 | 97.97K |
| Sep 1, 2026 | $11.02 | $11.125 | $10.83 | $11.07 | 96.24K |
Latest KROS news
The latest Smart Investors Daily articles mentioning KROS.
Stock researchResearch & News · Analysis
Company
OverviewForecastEarnings — requires Earnings Calls and Results accessDividend — requires Dividend Research accessFinancials
Market Activity
OptionsInsider Trades — requires Insider Buying and Selling accessShort InterestInstitutional Ownership — requires Institutional Ownership accessSentiment
Research & News
Loading stock research…